Immediate and Late Outcomes of Bronchial and Systemic Artery Embolization for Palliative Treatment of Patients With Nonsmall-Cell Lung Cancer Having Hemoptysis' m) L* W* v7 E/ y9 Y( w U. u& J7 b
Background: Hemoptysis in patients with advanced lung cancer can be a life threatening.$ o7 A* y7 B/ R- |$ u
Objectives: To evaluate immediate outcomes and late outcomes of bronchial artery embolization (BAE) for palliative treatment in patients with advanced nonsmall-cell lung cancer (NSCLC) having hemoptysis. ( d |+ k. I. B7 c% rMethods: The BAE was performed in 28 patients with NSCLC. Hemoptysis was defined as follows: massive bleeding greater than 300 mL within 24 hours (n = 8), moderate bleeding of 100 to 300 mL within 24 hours (n =12), and slight bleeding less than100 mL within 24 hours (n = 8). ! R0 e+ E- G* s0 i- c8 I7 i9 iResults: Success rate was 96%. Immediate clinical success within 24 hours after BAE was achieved in 22 of the 27 patients who underwent embolization. ! H B% T6 q( M( q" E, l+ Q% A( VConclusions: The BAE with gelatin sponge particles can provide good management of hemoptysis as a palliative treatment in patients with advanced NSCLC.